cell wall disruption

Inhibitory and synergistic effects of volatile organic compounds from bat caves against Pseudogymnoascus destructans in vitro

mycolabadmin

Researchers discovered that two natural compounds found in bat cave environments—isovaleric acid and ethyl methyl carbonate—can effectively kill the fungus that causes white-nose syndrome in bats. When used together, these compounds work even better than alone, disrupting the fungus’s cell membranes, causing it to produce too many reactive molecules (free radicals), and triggering cell death. This discovery offers hope for developing new treatments to protect bat populations that have been devastated by this disease in North America.

Cystobacter fuscus HM-E: a novel biocontrol agent against cotton Verticillium wilt

mycolabadmin

A naturally occurring bacterium called Cystobacter fuscus shows great promise as a biological control agent against a serious fungal disease that damages cotton plants. When formulated as a solid product and applied to soil, this microorganism was able to prevent disease in over 70% of cotton plants tested in greenhouse experiments. The bacteria work by attacking and breaking down the fungal pathogen while also promoting healthier plant growth, offering farmers an environmentally friendly alternative to chemical fungicides.

Plants, fungi, and antifungals: A little less talk, a little more action

mycolabadmin

Researchers propose looking at how plants communicate with fungi to discover new antifungal medicines. Plants send chemical signals to fungi, and understanding these signals could help us develop better treatments for fungal infections in humans and crops. By studying a simple yeast model, scientists found that plant molecules called strigolactones control fungal phosphate metabolism, suggesting they could become new drug targets.

Screening microbial inhibitors of Pseudogymnoascus destructans in Northern China

mycolabadmin

Scientists in Northern China have found bacteria living on bat skin and in cave soil that can kill the fungus responsible for white-nose syndrome, a disease devastating bat populations worldwide. These bacteria produce various antifungal compounds including volatile organic compounds that diffuse through the air and damage the fungus’s structure. By analyzing the genetic makeup of these bacteria, researchers identified specific genes responsible for producing these antifungal compounds, offering hope for developing biological control treatments that could protect bats and reduce fungal loads in cave environments.

Inhibitory Effects and Mechanisms of Perilla Essential Oil and Perillaldehyde against Chestnut Pathogen Botryosphaeria dothidea

mycolabadmin

Chestnut rot caused by the fungus Botryosphaeria dothidea is a major problem during fruit storage. Researchers found that essential oil from perilla plants and its main component perillaldehyde effectively kill this fungus by damaging its cell walls and membranes. This natural solution could replace harmful synthetic fungicides while keeping chestnuts fresh longer during storage.

Discovery of novel targets for important human and plant fungal pathogens via an automated computational pipeline HitList

mycolabadmin

Researchers created a computer program called HitList that searches fungal DNA to find new targets for antifungal medications. The program identified 16 promising protein targets that could be attacked by new antifungal drugs, including 8 completely new targets never before considered. This discovery could help develop new antifungal treatments to fight drug-resistant fungal infections in both humans and crops.

Past, present and future of antifungals: Advancements in mechanisms of action and resistance

mycolabadmin

Fungal infections are a growing global health threat, especially for people with weakened immune systems, causing millions of deaths annually. Currently available antifungal drugs are limited and increasingly face resistance, making them less effective over time. This special collection of research papers explores new approaches to treating fungal infections, including novel drugs, combination therapies, and alternative treatments to overcome resistance. Scientists and doctors hope these advances will help save more lives by providing better options for treating serious fungal diseases.

Healthcare-associated fungal infections and emerging pathogens during the COVID-19 pandemic

mycolabadmin

During the COVID-19 pandemic, fungal infections became a serious complication in hospitalized patients, especially those receiving steroids and other immune-suppressing treatments. Common fungal pathogens like Candida and Aspergillus caused dangerous coinfections, with infection rates varying significantly by region. Current antifungal medications have significant limitations including toxicity and resistance, highlighting the urgent need for new and safer antifungal treatments.

Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives

mycolabadmin

This review examines how doctors treat serious fungal infections and the growing problem of fungi becoming resistant to medications. The authors discuss different antifungal drugs, how they work, and why some fungi are becoming harder to treat. They emphasize that controlling fungal resistance requires coordinated efforts across hospitals, farms, and communities, especially since some agricultural pesticides are creating resistant strains that spread to sick patients.

Clinical aspects and recent advances in fungal diseases impacting human health

mycolabadmin

Fungal infections are becoming a major health threat, affecting over a billion people worldwide. The main problems are difficulty diagnosing these infections, increasing resistance to current medications, and limited treatment options. Doctors and the public need better awareness, and new antifungal drugs with different approaches are needed to effectively treat resistant infections.

therapeutic action: cell wall disruption